Melissa M. Tomkiel, President and General Counsel of Blade Air Mobility ($BLDE), made two open market sales of company shares over the past year, totaling about $645,000. Her most recent sale occurred on August 4, 2025. These transactions rank her 5,942nd among nearly 12,000 insiders by sale value, below the average of $8.6 million across about 6.4 sales per insider. She reported no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 8, 2026 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | Co-CEO and General Counsel | F | Class A common stock, $0.0001 par value per share | 29372 | $4.54 | 1,613,990.0000 | 86,366,526 | 1.79% | 0.03% |
| Jan. 2, 2026 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | Co-CEO and General Counsel | M | Stock Option (right to buy) | 276960 | $0.00 | 0.0000 | 86,366,526 | 100.00% | 0.32% |
| Jan. 2, 2026 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | Co-CEO and General Counsel | M | Class A common stock, $0.0001 par value per share | 276960 | $0.18 | 1,643,362.0000 | 86,366,526 | 20.27% | 0.32% |
| Dec. 10, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | Co-CEO and General Counsel | F | Class A common stock, $0.0001 par value per share | 34018 | $4.38 | 1,366,402.0000 | 86,366,526 | 2.43% | 0.04% |
| Nov. 7, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | Co-CEO and General Counsel | M | Class A common stock, $0.0001 par value per share | 27778 | $0.18 | 1,400,420.0000 | 86,366,526 | 2.02% | 0.03% |
| Nov. 7, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | Co-CEO and General Counsel | M | Stock Option (right to buy) | 27778 | $0.00 | 276,960.0000 | 86,366,526 | 9.12% | 0.03% |
| Oct. 31, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | Co-CEO and General Counsel | A | Class A common stock, $0.0001 par value per share | 208929 | $0.00 | 1,479,301.0000 | 79,694,028 | 16.45% | 0.26% |
| Nov. 3, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | Co-CEO and General Counsel | F | Class A common stock, $0.0001 par value per share | 106659 | $5.03 | 1,372,642.0000 | 79,694,028 | 7.21% | 0.13% |
| Oct. 22, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | Co-CEO and General Counsel | M | Stock Option (right to buy) | 55556 | $0.00 | 304,738.0000 | 79,694,028 | 15.42% | 0.07% |
| Oct. 22, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | Co-CEO and General Counsel | M | Class A common stock, $0.0001 par value per share | 55556 | $0.18 | 1,270,372.0000 | 79,694,028 | 4.57% | 0.07% |
| Oct. 10, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | Co-CEO and General Counsel | M | Stock Option (right to buy) | 55555 | $0.00 | 360,294.0000 | 79,694,028 | 13.36% | 0.07% |
| Oct. 10, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | Co-CEO and General Counsel | M | Class A common stock, $0.0001 par value per share | 55555 | $0.18 | 1,214,816.0000 | 79,694,028 | 4.79% | 0.07% |
| Sept. 10, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | Co-CEO and General Counsel | F | Class A common stock, $0.0001 par value per share | 34018 | $4.00 | 1,159,261.0000 | 79,694,028 | 2.85% | 0.04% |
| Aug. 6, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Stock Option (right to buy) | 20500 | $0.00 | 439,794.0000 | 79,694,028 | 4.45% | 0.03% |
| Aug. 7, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Stock Option (right to buy) | 23945 | $0.00 | 415,849.0000 | 79,694,028 | 5.44% | 0.03% |
| Aug. 6, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Class A common stock, $0.0001 par value per share | 20500 | $0.18 | 1,169,334.0000 | 79,694,028 | 1.78% | 0.03% |
| Aug. 7, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Class A common stock, $0.0001 par value per share | 23945 | $0.18 | 1,193,279.0000 | 79,694,028 | 2.05% | 0.03% |
| Aug. 4, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | S | Class A common stock, $0.0001 par value per share | 47995 | $4.94 | 1,148,834.0000 | 79,694,028 | 4.01% | 0.06% |
| Aug. 1, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | A | Class A common stock, $0.0001 par value per share | 160714 | $0.00 | 1,277,900.0000 | 79,694,028 | 14.39% | 0.20% |
| Aug. 1, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | F | Class A common stock, $0.0001 par value per share | 81071 | $3.99 | 1,196,829.0000 | 79,694,028 | 6.34% | 0.10% |
| June 10, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | F | Class A common stock, $0.0001 par value per share | 34018 | $3.80 | 1,117,186.0000 | 79,694,028 | 2.95% | 0.04% |
| June 9, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | S | Class A common stock, $0.0001 par value per share | 100000 | $4.08 | 1,151,204.0000 | 79,694,028 | 7.99% | 0.13% |
| March 28, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Class A common stock, $0.0001 par value per share | 27777 | $0.18 | 1,251,204.0000 | 79,694,028 | 2.27% | 0.03% |
| March 26, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Stock Option (right to buy) | 27779 | $0.00 | 488,071.0000 | 79,694,028 | 5.39% | 0.03% |
| March 28, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Stock Option (right to buy) | 27777 | $0.00 | 460,294.0000 | 79,694,028 | 5.69% | 0.03% |
| March 26, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Class A common stock, $0.0001 par value per share | 27779 | $0.18 | 1,223,427.0000 | 79,694,028 | 2.32% | 0.03% |
| March 13, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | A | Class A common stock, $0.0001 par value per share | 257143 | $0.00 | 1,362,265.0000 | 79,694,028 | 23.27% | 0.32% |
| March 13, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | F | Class A common stock, $0.0001 par value per share | 132326 | $3.12 | 1,229,939.0000 | 79,694,028 | 9.71% | 0.17% |
| March 13, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | F | Class A common stock, $0.0001 par value per share | 34291 | $3.12 | 1,195,648.0000 | 79,694,028 | 2.79% | 0.04% |
| Jan. 8, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Stock Option (right to buy) | 6264 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 10, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Class A common stock, $0.0001 par value per share | 50000 | $0.18 | 1,105,122.0000 | 0 | 4.74% | 0.00% |
| Jan. 8, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Class A common stock, $0.0001 par value per share | 27716 | $0.18 | 1,055,122.0000 | 0 | 2.70% | 0.00% |
| Jan. 8, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Class A common stock, $0.0001 par value per share | 16020 | $0.18 | 1,027,406.0000 | 0 | 1.58% | 0.00% |
| Jan. 8, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Class A common stock, $0.0001 par value per share | 6264 | $0.18 | 1,011,386.0000 | 0 | 0.62% | 0.00% |
| Jan. 10, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Stock Option (right to buy) | 50000 | $0.00 | 515,850.0000 | 0 | 8.84% | 0.00% |
| Jan. 8, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Stock Option (right to buy) | 27716 | $0.00 | 565,850.0000 | 0 | 4.67% | 0.00% |
| Jan. 8, 2025 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Stock Option (right to buy) | 16020 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 11, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | F | Class A common stock, $0.0001 par value per share | 34018 | $4.72 | 1,005,122.0000 | 0 | 3.27% | 0.00% |
| Dec. 9, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | S | Class A common stock, $0.0001 par value per share | 22486 | $5.01 | 1,039,140.0000 | 0 | 2.12% | 0.00% |
| Nov. 29, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | S | Class A common stock, $0.0001 par value per share | 22135 | $5.02 | 1,061,626.0000 | 0 | 2.04% | 0.00% |
| Nov. 27, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | S | Class A common stock, $0.0001 par value per share | 44621 | $4.25 | 1,128,382.0000 | 0 | 3.80% | 0.00% |
| Nov. 27, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | S | Class A common stock, $0.0001 par value per share | 44621 | $4.50 | 1,083,761.0000 | 0 | 3.95% | 0.00% |
| Nov. 12, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | S | Class A common stock, $0.0001 par value per share | 44621 | $3.40 | 1,173,003.0000 | 0 | 3.66% | 0.00% |
| Sept. 11, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | F | Class A common stock, $0.0001 par value per share | 34018 | $2.85 | 1,217,624.0000 | 0 | 2.72% | 0.00% |
| June 13, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | F | Class A common stock, $0.0001 par value per share | 60834 | $2.94 | 1,251,642.0000 | 0 | 4.64% | 0.00% |
| June 10, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Stock Option (right to buy) | 10253 | $0.18 | 6,264.0000 | 0 | 62.08% | 0.00% |
| June 10, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Class A common stock, $0.0001 par value per share | 10253 | $0.18 | 1,312,476.0000 | 0 | 0.79% | 0.00% |
| April 3, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | S | Class A common stock, $0.0001 par value per share | 11734 | $3.28 | 1,302,223.0000 | 0 | 0.89% | 0.00% |
| April 3, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | S | Class A common stock, $0.0001 par value per share | 22836 | $3.28 | 1,291,121.0000 | 0 | 1.74% | 0.00% |
| March 18, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Stock Option (right to buy) | 27857 | $0.18 | 16,517.0000 | 0 | 62.78% | 0.00% |
| March 18, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Class A common stock, $0.0001 par value per share | 27857 | $0.18 | 1,313,957.0000 | 0 | 2.17% | 0.00% |
| March 13, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | S | Class A common stock, $0.0001 par value per share | 26191 | $2.76 | 1,256,179.0000 | 0 | 2.04% | 0.00% |
| March 15, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Stock Option (right to buy) | 9068 | $0.18 | 0.0000 | 0 | 100.00% | 0.00% |
| March 14, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | S | Class A common stock, $0.0001 par value per share | 25634 | $2.62 | 1,230,545.0000 | 0 | 2.04% | 0.00% |
| March 15, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Class A common stock, $0.0001 par value per share | 46487 | $0.18 | 1,277,032.0000 | 0 | 3.78% | 0.00% |
| March 15, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Class A common stock, $0.0001 par value per share | 9068 | $0.18 | 1,286,100.0000 | 0 | 0.71% | 0.00% |
| March 15, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Stock Option (right to buy) | 46487 | $0.18 | 44,374.0000 | 0 | 51.16% | 0.00% |
| March 8, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | A | Class A common stock, $0.0001 par value per share | 22836 | $0.00 | 1,282,370.0000 | 0 | 1.81% | 0.00% |
| Jan. 2, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Class A common stock, $0.0001 par value per share | 30148 | $0.18 | 1,259,534.0000 | 0 | 2.45% | 0.00% |
| Jan. 2, 2024 | Strata Critical Medical, Inc. | $SRTA | Tomkiel Melissa M. | President and General Counsel | M | Stock Option (right to buy) | 30148 | $0.18 | 9,068.0000 | 0 | 76.88% | 0.00% |